Activation of kinin B1 receptor increases the release of metalloproteases-2 and -9 from both estrogen-sensitive and -insensitive breast cancer cells

Cancer Letters

Volumn 301, Issue 1, 2011, Pages 106-118

  Ehrenfeld, Pamela ^a   Conejeros, Ivan ^a   Pavicic, Maria F ^a   Matus, Carola E ^a   Gonzalez, Carlos B ^a   Quest, Andrew F G ^b   Bhoola, Kanti D ^c   Poblete, Maria T ^a   Burgos, Rafael A ^a   Figueroa, Carlos D ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bradykinin; Breast cancer invasion; Extracellular matrix; MCF 7 cells; MDA MB 231 cells; Metastasis; MMP 2; MMP 9

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BRADYKININ B1 RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; GENETIC TRANSFECTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RECEPTOR, BRADYKININ B1;

EID: 78650558263     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.09.020     Document Type: Article

References (57)

1. Bhoola K.D., Worthy K., Figueroa C.D. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 1992, 44:1-80.
2. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 2005, 57:27-77.
3. K.D. Bhoola, E. Fink, Kallikrein-kinin cascade, in: Encyclopedia of Respiratory Medicine, Elsevier Ltd., The Boulevard, Langford Lane, Kidlington, Oxford OX2 1GB, UK, 2006, pp. 483-493.
4. Magklara A., Scorilas A., Lopez-Otin C., Vizoso F., Ruibal A., Diamandis E.P. Human glandular kallikrein in breast, milk, amniotic fluid, and breast cyst fluid. Clin. Chem. 1999, 45:1774-1780.
5. Rehbock J., Buchinger P., Hermann A., Figueroa C.D. Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas. J. Cancer Res. Clin. Oncol. 1995, 121:64-68.
6. Hermann A., Buchinger P., Rehbock J. Visualization of tissue kallikrein in human breast carcinomas by two-dimensional western blotting and immunohistochemistry. Biol. Chem. 1995, 376:365-370.
7. Marceau F. Kinin B1 receptors: a review. Int. Immunopharmacol. 1995, 30:1-26.
8. Greco S., Muscella A., Elia M.G., Romano S., Storelli C., Marsigliante S. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. J. Cell. Physiol. 2004, 201:84-96.
9. Greco S., Elia M.G., Muscella A., Romano S., Storelli C. Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture. J. Endocrinol. 2005, 186:291-301.
10. Greco S., Storelli C., Marsigliante S. Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J. Endocrinol. 2006, 188:79-89.
11. M.T. Poblete, C.E. Matus, E. Tapia, J.A. Perez, C.B. Gonzalez, L. Molina, F. Nualart, C.D. Figueroa, Breast Tumours and MCF-7 Cells Express Kinin B1 and B2 Receptors, The National Cancer Research Institute Cancer Conference. Birmingham, UK, 2006, pp. 170.
12. Esseghir S., Reis-Filho J.S., Kennedy A., James M., O'Hare M.J., Jeffery R., Poulsom R., Isacke C.M. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts. J. Pathol. 2006, 210:420-430.
13. Molina L., Matus C.E., Astroza A., Pavicic F., Tapia E., Toledo C., Perez J.A., Nualart F., Gonzalez C.B., Burgos R.A., Figueroa C.D., Ehrenfeld P., Poblete M.T. Stimulation of the bradykinin B1 receptor induces the proliferation of estrogen-sensitive breast cancer cells and activates the ERK1/2 signaling pathway. Breast Cancer Res. Treat. 2009, 118:499-510.
14. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
15. Chang C., Werb Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell. Biol. 2001, 11:S37-S43.
16. Johnsen M., Lund L.R., Romer J., Almholt K., Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell. Biol. 1998, 10:667-671.
17. Poulsom R., Hanby A.M., Pignatelli M., Jeffery R.E., Longcroft J.M., Rogers L. Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J. Clin. Pathol. 1993, 46:429-436.
18. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
19. Liabakk N.B., Talbot I., Smith R.A., Wilkinson K., Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 1996, 56:190-196.
20. Vu T.H. Don't mess with the matrix. Nat. Genet. 2001, 28:202.
21. Talvensaari-Mattila A., Paakko P., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Brit. J. Cancer 2003, 89:1270-1275.
22. Rowe R.G., Weiss S.J. Breaching the basement membrane: who, when and how?. Trends Cell. Biol. 2008, 18:560-574.
23. Cho S.G., Choi E.J. Apoptotic signaling pathways: caspases and stress-activated protein kinases. J. Biochem. Mol. Biol. 2002, 35:24-27.
24. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 2001, 17:463-516.
25. Korff T., Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell. Biol. 1998, 143:1341-1352.
26. Ehrenfeld P., Matus C.E., Pavicic F., Toledo C., Nualart F., Gonzalez C.B., Burgos R.A., Bhoola K.D., Figueroa C.D. Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase family. J. Leukocyte Biol. 2009, 86:1179-1189.
27. Ehrenfeld P., Millan C., Matus C.E., Figueroa J., Burgos R.A., Nualart F., Bhoola K.D., Figueroa C.D. Activation of kinin B1 receptors induces chemotaxis of human neutrophils. J. Leukocyte Biol. 2006, 80:117-124.
28. Lamar J.M., Iyer V., di Persio C.M. Integrin alpha3beta1 potentiates TGF beta-mediated induction of MMP-9 in immortalized keratinocytes. J. Invest. Dermatol. 2008, 128:575-586.
29. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
30. Chambers A.F., Groom A.C., MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2:563-572.
31. Pantel K., Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4:448-456.
32. Geho D.H., Bandle R.W., Clair T., Liotta L.A. Physiological mechanisms of tumor-cell invasion and migration. Physiology (Bethesda) 2005, 20:194-200.
33. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
34. Lynch C.C., Matrisian L.M. Matrix metalloproteinases in tumor host cell communication. Differentiation 2002, 70:561-573.
35. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front. Biosci. 2006, 11:479-491.
36. Das S., Banerji A., Frei E., Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008, 82:467-476.
37. Esparza J., Vilardell C., Calvo J., Juan M., Vives J., Urbano-Marquez A., Yague J., Cid M.C. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 1999, 94:2754-2766.
38. Cortes-Reinosa P., Robledo T., Macias-Silva M., Wu V., Perez E. Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2008, 27:220-231.
39. Hanemaaijer R., Verheijen J.H., Maguire T.M., Visser H., Toet K., McDermott E., O'Higgins N., Duffy M.J. Increased gelatinase-A and gelatinase-B activities in malignant vs benign breast tumors. Int. J. Cancer 2000, 86:204-217.
40. Jezierska A., Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med. Sci. Monit. 2009, 15:32-40.
41. Lee K.S., Rha S.Y., Kim S.J., Kim J.H., Roh J.K., Kim B.S., Chung H.C. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression. Clin. Exp. Metastas. 1996, 4:512-519.
42. Köhrmann A., Kammerer U., Kapp M., Dietl J., Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 2009, 9:88-208.
43. Gschwind A., Zwick E., Prenzel N., Leserer M., Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 2001, 20:1594-1600.
44. Keen J.C., Davison N.E. The biology of breast cancer carcinoma. Cancer 2003, 97:825-833.
45. Roskoski R. The Erb/HER receptor protein-tyrosine kinases and cancer. Biochem. Biophys. Res. Commun. 2004, 319:1-11.
46. Ali S., Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2002, 2:101-112.
47. Nicholson R.I., Gee J.M., Knowlden J., McClelland R., Madden T.A., Barrow D., et al. The biology of antihormone failure in breast cancer. Breast Cancer Res. Treat. 2003, 80:29-34.
48. McCaweley L.J., Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 2000, 6:149-156.
49. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase- 9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14:163-176.
50. Yu Q., Stamenkovic I. Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival. Clin. Exp. Metastas. 2004, 21:235-242.
51. Rolli M., Fransvea E., Pilch J., Saven A., Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. (USA) 2003, 5:9482-9487.
52. Thomas G.J., Lewis M.P., Hart I.R., Marshall J.F., Speight P.M. Alpha vbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int. J. Cancer 2001, 92:641-650.
53. Brooks P.C., Strömblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., Quigley J.P., Cheresh D.A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha vbeta 3. Cell 1996, 85:683-693.
54. Orlichenko L.S., Radisky D.C. Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development. Clin. Exp. Metastas. 2008, 25:593-600.
55. Bergers G., Brekken R., McMahon G., Vu T., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell. Biol. 2000, 2:737-744.
56. Rodríguez-Manzaneque J., Lane T., Ortega M., Hynes R., Lawler J., Iruela-Arispe M. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc. Natl. Acad. Sci. (USA) 2001, 98:12485-12490.
57. Chabottaux V., Noel A. Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin. Exp. Metastas. 2007, 24:647-656.